CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar GreatStocks3728 (< 20) Submitted: 2/2/2010 4:18:07 PM : Outperform Start Price: $6.32 CRY Score: -47.28

Goog growth and earnings.

Report this Post 1 Comment
Member Avatar ngc598 (< 20) Submitted: 2/13/2010 1:28:36 PM
Recs: 0

Hi,

i am new here...i noticed CRY`s Q3 was a negative surprise....would anyone care to share their guess as to Q4 and 2009 as a whole...
Thanks, and btw great community here!

Featured Broker Partners


Advertisement